FdaApplication
ANDA 213110
Identifiers
- fda_app_no: ANDA213110
Properties
| Property | Value |
|---|---|
| applicant_name | CHARTWELL MOLECULAR HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2020-04-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CLOBAZAM | CLOBAZAM | 2.5MG/ML | SUSPENSION;ORAL |
1 product